A descriptive survey study in endocrinology clinic: evaluation of the use of natural products

References

• International Diabetes Federation. 2021. IDF Guide for Epidemiology Studies [Online]. Available from: https://diabetesatlas.org/idf-guide-for-epidemiology-studies/
   Google Scholar
• Nuhoglu İ, Deger O, Topbaş M, et al. The prevalence of diabetes and associated risk factors among adult population in a turkish population (trabzon city). Prim Care Diabetes. 2022;16(4):549–554. doi: 10.1016/j.pcd.2022.05.010.
   PubMed Web of Science ®Google Scholar
• Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi: 10.1210/jcem.87.2.8182.
   PubMed Web of Science ®Google Scholar
• Kutluturk F, Yildirim B, Ozturk B, et al. Thyroid dysfunctions and sonographic characteristics in Northern Turkey: a population-based study. Ann Saudi Med. 2013;33(3):253–259. doi: 10.5144/0256-4947.2013.253.
   PubMed Web of Science ®Google Scholar
• Durante C, Grani G, Lamartina L, et al. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914–924. doi: 10.1001/jama.2018.0898.
   PubMed Web of Science ®Google Scholar
• Kocak M, Erem C, Deger O, et al. Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine-deficient area of Turkey. Endocrine. 2014;47(1):290–298. doi: 10.1007/s12020-013-0153-2.
   PubMed Web of Science ®Google Scholar
• Gebremichael G, Demena M, Egata G, et al. Prevalence of goiter and associated factors among adolescents in gazgibla district, northeast Ethiopia. Glob Adv Health Med. 2020;9:2164956120923624. doi: 10.1177/2164956120923624.
   Google Scholar
• Turkish Society of Endocrinology and Metabolism. TEMD pituitary diseases diagnosis, treatment and follow-up guide. 2022. Available from http://www.temd.org.tr
   Google Scholar
• Turkish Society of Endocrinology and Metabolism. TEMD guide to adrenal and gonadal diseases. 2020. Available from http://www.temd.org.tr
   Google Scholar
• WHO Expert Committee on Specifications for Pharmaceutical Preparations, Fifty-second report. 2023. Available from https://apps.who.int/iris/bitstream/handle/10665/272452/9789241210195-eng.pdf?sequence=1&isAllowed=y
   Google Scholar
• Ali-Shtayeh MS, Jamous RM, Jamous RM. Complementary and alternative medicine use amongst palestinian diabetic patients. Complement Ther Clin Pract. 2012;18(1):16–21. doi: 10.1016/j.ctcp.2011.09.001.
   PubMedGoogle Scholar
• Rosen JE, Gardiner P, Saper RB, et al. Complementary and alternative medicine use among patients with thyroid cancer. Thyroid. 2013;23(10):1238–1246. doi: 10.1089/thy.2012.0495.
   PubMed Web of Science ®Google Scholar
• Kalkan Ş. Drug interactions in the treatment with herbal products. DEU Tıp Derg. 2017;31(1):41–50.
   Google Scholar
• Hashempur MH, Mosavat SH, Heydari M, et al. Medicinal plants’ use among patients with dyslipidemia: an iranian cross-sectional survey. J Complement Integr Med. 2018;16(3):20180101. doi: 10.1515/jcim-2018-0101.
   PubMedGoogle Scholar
• Joachimdass RJ, Subramaniam K, Sit NW, et al. Self-management using crude herbs and the health-related quality of life among adult patients with hypertension living in a suburban setting of Malaysia. PLoS One. 2021;16(9):e0257336. doi: 10.1371/journal.pone.0257336.
   PubMed Web of Science ®Google Scholar
• Dişli M, Yeşilada E. Herbal medicinal products in Turkey (standardization, production and adulteration of herbal products in Turkey. J. Biotechnol and Strategic Health. Res. 2019;3:13–21.
   Google Scholar
• OpenEpi. 2021. Available from: https://www.openepi.com/SampleSize/SSPropor.htm
   Google Scholar
• World Health Organization. 2013. Obesity and overweight. WHO fact sheet No 311. Available from: www.who.int/mediacentre/factsheets/fc311/en/
   Google Scholar
• Rosenzweig JL, Weinger K, Poirier-Solomon L, et al. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. Am J Manag Care. 2002;8(11):950–958.
   PubMed Web of Science ®Google Scholar
• Linzer M, Pierce C, Lincoln E, et al. Preliminary validation of a patient-based self-assessment measure of severity of illness in type 2 diabetes: results from the pilot phase of the veterans health study. J Ambul Care Manage. 2005;28(2):167–176. doi: 10.1097/00004479-200504000-00007.
   PubMedGoogle Scholar
• Nahin RL, Byrd-Clark D, Stussman BJ, et al. Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 national health interview survey. BMC Complement Altern Med. 2012;12(1):193. doi: 10.1186/1472-6882-12-193.
   PubMedGoogle Scholar
• Timbo BB, Ross MP, McCarthy PV, et al. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc. 2006;106(12):1966–1974. doi: 10.1016/j.jada.2006.09.002.
   PubMedGoogle Scholar
• Pouchieu C, Andreeva VA, Péneau S, et al. Sociodemographic, lifestyle and dietary correlates of dietary supplement use in a large sample of french adults: results from the NutriNet-Santé cohort study. Br J Nutr. 2013;110(8):1480–1491. doi: 10.1017/S0007114513000615.
   PubMed Web of Science ®Google Scholar
• Radwan H, Hasan H, Hamadeh R, et al. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates. BMC Complement Med Ther. 2020;20(1):216. doi: 10.1186/s12906-020-03011-5.
   PubMedGoogle Scholar
• Adeniyi O, Washington L, Glenn CJ, et al. The use of complementary and alternative medicine among hypertensive and type 2 diabetic patients in Western Jamaica: a mixed methods study. PLoS One. 2021;16(2):e0245163. doi: 10.1371/journal.pone.0245163.
   PubMed Web of Science ®Google Scholar
• Fidancı İ, Öztürk O. Phytotherapy methods of the patients in the treatment of hyperlipidemia. Turk J Bioch. 2017;6(1):6–13. doi: 10.5505/abantmedj.2017.47965.
   Google Scholar
• Chetoui A, Kaoutar K, Boutahar K, et al. Herbal medicine use among moroccan type 2 diabetes patients in the Beni Mellal-Khenifra region. J Herb Med. 2021;29:100480. doi: 10.1016/j.hermed.2021.100480.
   Web of Science ®Google Scholar
• Alqathama A, Alluhiabi G, Baghdadi H, et al. Herbal medicine from the perspective of type II diabetic patients and physicians: what is the relationship? BMC Complement Med Ther. 2020;20(1):65. doi: 10.1186/s12906-020-2854-4.
   PubMedGoogle Scholar
• Amaeze OU, Aderemi-Williams RI, Ayo-Vaughan MA, et al. Herbal medicine use among type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use. Int J Clin Pharm. 2018;40(3):580–588. doi: 10.1007/s11096-018-0648-2.
   PubMed Web of Science ®Google Scholar
• Rafi MA, Azad DT, Bhattacharjee M, et al. A hospital-based study on complementary and alternative medicine use among diabetes patients in Rajshahi, Bangladesh. BMC Complement Med Ther. 2020;20(1):219. doi: 10.1186/s12906-020-03021-3.
   PubMedGoogle Scholar
• Dinçoğlu H. Rational drug use in diabetes mellitus for primary care. tjtfp. 2020;11(3):131–140. doi: 10.15511/tjtfp.20.00331.
   Google Scholar
• Dirikoç A, Genç B, Ozdemir D, et al. Adherence to levothyroxine treatment and factors related with adherence in patients with hypothyroidism. Ankara Med J. 2021;21(2):261–273. doi: 10.5505/amj.2021.24572.
   Google Scholar
• Behl T, Rana T, Sehgal A, et al. Phytochemicals targeting nitric oxide signaling in neurodegenerative diseases. Nitric Oxide. 2023;130:1–11. doi: 10.1016/j.niox.2022.11.001.
   PubMed Web of Science ®Google Scholar
• Behl T, Rocchetti G, Chadha S, et al. Phytochemicals from plant foods as potential source of antiviral agents: an overview. Pharmaceuticals (Basel). 2021;14(4):381. doi: 10.3390/ph14040381.
   PubMedGoogle Scholar
• Malhotra SPK, Mandal TK. Phytochemical screening and in vitro antibacterial activity of moringa oleifera lam., leaf extract. Arch Agri Environ Sci. 2018;3(4):367–372. doi: 10.26832/24566632.2018.030406.
   Google Scholar
• Alam F, Shafique Z, Amjad ST, et al. Enzymes inhibitors from natural sources with antidiabetic activity: a review. Phytother Res. 2019;33(1):41–54. doi: 10.1002/ptr.6211.
   PubMed Web of Science ®Google Scholar
• Bai RR, Wu XM, Xu JY. Current natural products with antihypertensive activity. Chin J Nat Med. 2015;13(10):721–729. doi: 10.1016/S1875-5364(15)30072-8.
   PubMed Web of Science ®Google Scholar
• Arulselvan P, Fard MT, Tan WS, et al. Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016;2016(2016):5276130. doi: 10.1155/2016/5276130.
   PubMedGoogle Scholar